HPV Pilot Action Indonesia

Informazioni relative al progetto

PAHPV-1

ID dell’accordo di sovvenzione: 502455

Progetto chiuso

Data di avvio 15 Aprile 2004

Data di completamento 14 Agosto 2005

Finanziato da

• Specific measures in support of international cooperation: Specific activities covering wider field of research under the Focusing and Integrating Community Research programme 2002-2006.

Costo totale € 132 000,00

Contributo UE € 132 000,00

Coordinato da

LEIDEN UNIVERSITY MEDICAL CENTER
Netherlands

Obiettivo

HPV is the world's most common Sexually Transmitted Disease (STD). Every year 233.000 affected women ideas a result of progressive HPV related disease. Current data suggests that this is due to a lack or diminished immune response against high-risk HPV types.
Individuals who lack strong immunity may benefit from vaccination. In the world wide fight against HPV, a number of research centres are now developing(prophylactic) vaccines. LUMC and its EU-partners are one of the leading consortia. In this pilot action, Lucinda its counterparts in Indonesia (Jakarta and Bali) will run a clinical trial program in a study population of 200women to chart the percentage of individuals at risk for progressive HPV 16.
For this reason the incidence ofHPV16, as well as the immune response to this HPV type will be established. For this purpose the feasibility of simple, low cost DTH-skin test to detect HPV-immune reactivity will be tested. Once the DTH-skin test proves tube useful for detecting protective immune responses against HPV 16 it becomes within reach of other developing countries and will be helpful in the selection of individuals in need of specific vaccination. The test results will be cross-examined in Leiden (NL) with the results of a 'mirror-study' taking place at the sometime in Holland. Furthermore, the results of both studies (Leiden and Indonesia) will be implemented in forthcoming vaccination study against HIV’s this pilot action is to be incorporated in the running STD-education and prevention program of both local health centres, some basic education and training material on HPV will be developed for medical staff and target population.'

Campo scientifico

• medical and health sciences › basic medicine › immunology
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines
• medical and health sciences › clinical medicine › oncology › cervical cancer
• medical and health sciences › health sciences › infectious diseases › DNA viruses

Parole chiave

• HPV
• epidemiology
• health care system
• infection
• pilot action
• reproductive health
• study
• women

Programma(i)

• FP6-INCO - Specific measures in support of international cooperation: Specific activities covering wider field of research under the Focusing and Integrating Community Research programme 2002-2006.

Argomento(i)

• INCO-A.1 - Health and Public Health

Invito a presentare proposte

FP6-2002-INCO-DEV/SSA-1
Vedi altri progetti per questo bando

Meccanismo di finanziamento

SSA - Specific Support Action

Coordinatore

LEIDEN UNIVERSITY MEDICAL CENTER

• Contributo UE: Nessun dato
• Indirizzo: Albinusdreef 2 ; LEIDEN ; Paesi Bassi
• Costo totale: Nessun dato

Partecipanti (2)

UNIVERSITY OF INDONESIA

Indonesia

• Contributo UE: Nessun dato
• Indirizzo: Jalan Salemba 6 ; JAKARTA
• Costo totale: Nessun dato

RUMAH SAKIT SANGLAH

Indonesia

• Contributo UE: Nessun dato
• Indirizzo: Jalan Kasehatan, 1 ; DENPASAR
• Costo totale: Nessun dato